The Ethiopian Neonatal Network (ENN) represents one of the first low-income country neonatal quality improvement (QI) ...

A baby's first breaths involve more than just getting air into the lungs, and for the first time research has identified the ...

The FDA is examining the safety of shots that protect infants from respiratory syncytial virus (RSV), according to a report from Reuters. The agency has notified executives at AstraZeneca, Merck and ...

Objective To investigate whether the use of a biparametric score, based on lung ultrasound (LUS) and oxygen saturation/fraction of inspired oxygen ratio (SF ratio), in preterm infants with respiratory ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six ...

It’s a high-tech tool that could transform how doctors monitor breathing problems in babies. Respiratory diseases are among the leading causes of infant hospitalization, but typical monitoring devices ...

A recently immigrated mother from India presents in preterm labor at 32 6/7 weeks and delivers a vigorous baby whose initial blood culture is positive at 18 hours of life with gram negative rods. A 32 ...

A recently immigrated mother from India presents in preterm labor at 32 6/7 weeks and delivers a vigorous baby whose initial blood culture result is positive at 18 hours of life with gram-negative ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA™ (clesrovimab ...

The U.S. Food and Drug Administration has approved Merck's Enflonsia, a treatment to prevent respiratory syncytial virus lower respiratory tract disease in newborns and infants. The company said ...